Results 231 to 240 of about 19,792 (313)

Durometer to Objectively Measure the Hardness of Skin in Linear Morphea.

Int J Trichology
Satish N, Srinivas CR.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis

European Journal of Pharmaceutical Sciences, 2017
Sindhu Doppalapudi, Anjali Jain, Wahid Khan   +2 more
exaly   +2 more sources

hsa-miR-4516 Mediated Downregulation of STAT3/CDK6/UBE2N Plays a Role in PUVA Induced Apoptosis in Keratinocytes

Journal of Cellular Physiology, 2014
Neeru Saini
exaly   +2 more sources

Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study

British Journal of Dermatology, 2013
M. Berneburg, T. Herzinger, J. Rampf, W. Hoetzenecker, E. Guenova, C. Meisner, J. Maetzke, T. Schaefer, B. Eberlein, K. Scharffetter-Kochanek, M. Rocken   +10 more
exaly   +2 more sources

Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study

International Journal of Dermatology, 2012
Ranjeeta Sapam, S. Agrawal, T. Dhali
exaly   +2 more sources

UVB 308‐nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis

Journal of the European Academy of Dermatology and Venereology, 2011
S. Hammes, J. Hermann, S. Roos, Ockenfels Hm   +3 more
exaly   +2 more sources

Modifications of Puva

Dermatologic Clinics, 1995
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
K, Momtaz-T, T B, Fitzpatrick
openaire   +2 more sources

PUVA for Psoriasis

Dermatologic Clinics, 1995
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire   +2 more sources